PH21641A - 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives - Google Patents

1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives

Info

Publication number
PH21641A
PH21641A PH28813A PH28813A PH21641A PH 21641 A PH21641 A PH 21641A PH 28813 A PH28813 A PH 28813A PH 28813 A PH28813 A PH 28813A PH 21641 A PH21641 A PH 21641A
Authority
PH
Philippines
Prior art keywords
azanaphthyridine
naphthyridine
derivatives
azanaphthyridine derivatives
Prior art date
Application number
PH28813A
Other languages
English (en)
Inventor
Margaret H Sherlock
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/371,623 external-priority patent/US4452800A/en
Application filed by Schering Corp filed Critical Schering Corp
Publication of PH21641A publication Critical patent/PH21641A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH28813A 1982-04-26 1983-04-25 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives PH21641A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/371,623 US4452800A (en) 1982-04-26 1982-04-26 Salts of 3(n-butyl)-4-hydroxy-1-phenyl-1,8-naphthyridine-2(1H)-one and their use in treating chronic obstructive lung diseases
US43868182A 1982-11-03 1982-11-03

Publications (1)

Publication Number Publication Date
PH21641A true PH21641A (en) 1988-01-13

Family

ID=27005451

Family Applications (1)

Application Number Title Priority Date Filing Date
PH28813A PH21641A (en) 1982-04-26 1983-04-25 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives

Country Status (13)

Country Link
US (1) US4492702A (fr)
EP (1) EP0092786B1 (fr)
AU (1) AU553958B2 (fr)
CA (1) CA1198109A (fr)
DE (1) DE3368929D1 (fr)
DK (1) DK181983A (fr)
HK (1) HK20590A (fr)
IE (1) IE55113B1 (fr)
IL (1) IL68487A0 (fr)
NZ (1) NZ204004A (fr)
PH (1) PH21641A (fr)
PT (1) PT76596B (fr)
SG (1) SG76889G (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628055A (en) * 1982-11-03 1986-12-09 Schering Corporation Method for treating allergic reactions and compositions therefore
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
DE3481418D1 (de) * 1983-12-14 1990-04-05 Schering Corp Substituierte spiropyridinderivate, diese enthaltende pharmazeutische zubereitungen, verfahren zu ihrer herstellung und zubereitungen.
US4632923A (en) * 1984-08-15 1986-12-30 Schering Corporation Substituted hetero spiro pyridine derivatives as anti-allergy and anti-inflammatory agents
FR2567520B1 (fr) * 1984-07-11 1987-01-02 Carpibem Nouvelles phenyl-naphthyridines, leur procede de preparation, medicaments les contenant, notamment anti-ulceres
DK127086A (da) * 1985-03-25 1986-09-26 Schering Corp Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser
DE3669656D1 (de) * 1985-06-18 1990-04-26 Schering Corp Azanaphthalene enthaltende arzneimittelzusammensetzungen.
US4684727A (en) * 1985-07-29 1987-08-04 Schering Corporation Zwitterionic 1,8-naphthyridine and pyrazino[2,3-b]pyridine containing compounds useful as anti-allergic, anti-inflammatory and cycloprotective agents
US4760073A (en) * 1986-04-11 1988-07-26 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives, useful as anti-allergic agents
US5011860A (en) * 1986-04-11 1991-04-30 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases
US4917896A (en) * 1986-08-15 1990-04-17 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agents
US4916131A (en) * 1986-10-15 1990-04-10 Schering Corporation Naphthyridine derivatives and method for treating allergic reactions
US4775686A (en) * 1986-10-15 1988-10-04 Schering Corporation Naphthyridine derivatives and method for treating allergic reactions
EP0267691A3 (fr) * 1986-10-15 1989-08-23 Schering Corporation Utilisation de dérivés substitués en 1 de la naphthyridine et de la pyridopyrazine pour la préparation de médicaments utiles comme immunosuppresseurs.
US5037826A (en) * 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
US5045542A (en) * 1986-10-20 1991-09-03 Schering Corporation Immune suppression method employing aryl-substituted naphthyridine and pyridopyrazine derivatives
EP0267740A1 (fr) * 1986-11-06 1988-05-18 Schering Corporation Composés de naphtyridine et pyridopyrazine et leur utilisation pharmaceutique
US4897487A (en) * 1988-04-06 1990-01-30 Schering Corporation Process for preparing intermediates for pharmaceutically useful bicyclic compounds
JPH07116187B2 (ja) * 1987-07-22 1995-12-13 シェリング・コーポレーション 二環式化合物、それらを薬剤として使用すること、それらの製法、およびそれらの製造に有用な中間体
US4859669A (en) * 1987-12-23 1989-08-22 Schering Corporation Antiinflammatory and anti-hyperproliferative naphthyridin-4-ones
US5180823A (en) * 1988-04-06 1993-01-19 Schering Corporation Processes for preparing bicyclic compounds
US5079360A (en) * 1988-04-06 1992-01-07 Schering Corporation Processes for preparing bicyclic compounds and intermediates thereof
US4996212A (en) * 1989-12-21 1991-02-26 Schering Corporation Antiinflammatory and anti-hyperproliferative compounds
JP2988739B2 (ja) * 1990-04-16 1999-12-13 協和醗酵工業株式会社 １，８−ナフチリジン−２−オン誘導体
MX9701600A (es) * 1994-08-29 1997-05-31 Yamanouchi Pharma Co Ltd Derivados de naftiridina novedosos y composicion medicinal de los mismos.
CN1224624C (zh) 1999-12-08 2005-10-26 格勒兰制药株式会社 1,8－二氮杂萘－2(1h)－酮衍生物
ES2247325T3 (es) 2001-05-24 2006-03-01 MERCK FROSST CANADA & CO. Inhibidores de 1-biaril-1,8-naftiridin-4-ona fosfodiesterasa-4.
GB0614471D0 (en) 2006-07-20 2006-08-30 Syngenta Ltd Herbicidal Compounds
JP2012506885A (ja) * 2008-10-29 2012-03-22 ビーエーエスエフ ソシエタス・ヨーロピア 除草作用を有する置換ピリジン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5854152B2 (ja) * 1976-03-25 1983-12-02 久光製薬株式会社 新規なナフチリジン誘導体
US4128649A (en) * 1977-06-29 1978-12-05 Sandoz, Inc. 4-Hydroxy-pyrido[2,3-b]pyridine-2(1H)-one-3-carboxylic acids and esters
JP3774543B2 (ja) * 1997-06-17 2006-05-17 株式会社日立製作所 立軸ポンプおよびその駆動装置

Also Published As

Publication number Publication date
EP0092786B1 (fr) 1987-01-07
DK181983D0 (da) 1983-04-25
IL68487A0 (en) 1983-07-31
PT76596A (en) 1983-05-01
EP0092786A3 (en) 1984-07-25
IE55113B1 (en) 1990-06-06
EP0092786A2 (fr) 1983-11-02
AU553958B2 (en) 1986-07-31
HK20590A (en) 1990-03-23
DK181983A (da) 1983-10-27
DE3368929D1 (de) 1987-02-12
NZ204004A (en) 1986-03-14
PT76596B (en) 1986-02-27
AU1392783A (en) 1983-11-03
IE830934L (en) 1983-10-26
SG76889G (en) 1990-04-20
US4492702A (en) 1985-01-08
CA1198109A (fr) 1985-12-17

Similar Documents

Publication Publication Date Title
PH21641A (en) 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives
EP0097960A3 (en) Bis-crown-ether derivatives and their use
ZA832903B (en) 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives
IL61930A0 (en) 25-hydroxy-26,26,26,27,27,27-hexafluoroch-olecalciferol and derivatives thereof
DE3574380D1 (en) 1,8-naphthyridine derivatives
ZA83592B (en) Corynantheine derivatives,processes for their preparation,and their use
ZA868752B (en) 6,7,8,9-tetrahydro-10-methylpyrido(1,2-a)indol-9-amines and derivatives thereof
ZA856431B (en) 1,6-naphthyridine derivatives,process for the preparation and the use thereof
DE3365480D1 (en) Oxacephalosporin derivatives, their preparation and use
ZA845708B (en) Novel 1,8-naphthyridine derivatives,and processes for preparation thereof
GB8301383D0 (en) 3,3-dialkyl-and 3,3-alkylene-indoline derivatives
GB2087390B (en) 5,6,7,8-tetrahydro-1,6-naphthyridine derivatives and their preparation
IL68831A (en) 2,2-dimethyl-3-aryl-cyclo-butanones and their preparation
DE3479657D1 (en) 1-normonyl derivatives, processes and use
EG16141A (en) 1,2,4-triazol-1-yl-propionitrile derivatives their preparation and use
GB2124628B (en) 6-oxo-tetrahydropyran derivatives and cyanomethyl-azetidinones
AU550950B2 (en) N-phenylpyridinamines and pyrido(1,4)-benzodiazepines
IL70340A0 (en) Pyridone derivatives
GB2080794B (en) 1,6-naphthyridine derivatives
IL71769A0 (en) 4,4'-alkylenedipiperidine derivatives
ZA844618B (en) Tetrahydropyridazinone derivatives,processes for their preparation and their use
DE3368640D1 (en) 5,2',3',4',4",6"-hexadeoxykanamycin and its 1-n-acylated derivative
ZA832310B (en) 1,3,5-triacrylylhexahydro-s-triazine derivatives
GB2152036B (en) 4,5,6,7-tetrahydrobenzimidazole derivatives
IE820829L (en) Pyrazolopyridine derivatives